Suppr超能文献

软琼脂培养的人结肠腺癌细胞及无胸腺小鼠体内药物敏感性的相关性

Correlation of drug sensitivity on human colon adenocarcinoma cells grown in soft agar and in athymic mice.

作者信息

Zirvi K A, Masui H, Giuliani F C, Kaplan N O

出版信息

Int J Cancer. 1983 Jul 15;32(1):45-51. doi: 10.1002/ijc.2910320108.

Abstract

A well-differentiated colorectal tumor T 219 which grows as a xenograft in athymic mice (human-tumor-nude-mouse system) and forms colonies in culture (soft agar colony-formation assay) has been used to test the correlation between the above two methods of exposure of human tumor cells to antineoplastic agents. In in vitro studies, two protocols were used: 1 h drug exposure and continuous drug exposure. In the 1 h drug exposure experiments six drugs, doxorubicin (DX), 4'-deoxydoxorubicin (deoDX), 4'epidoxorubicin(epiDX), 4'-O-methyldoxorubicin (O-DX), N-trifluoroacetyldoxorubicin-14-valerate (AD-32) and 5-fluorouracil (FUra) were studied, while in continuous drug exposure experiments four of the above drugs (DX, deoDX, epiDX, O-DX) were studied. The survival of the tumor clonogenic cells (HC219) was determined by counting the number of colonies formed during 13-14 days of incubation and dose-response curves were obtained. In in vivo studies, the mice were treated with all of the drugs used in in vitro 1 h drug exposure experiments (DX, deoDX, epiDX, O-DX, AD-32 and FUra). To quantitate the chemotherapeutic effectiveness of the drugs, T/C% (relative tumor volume of treated group as percentage of the control group) values were calculated each time the tumors were measured. The experimental data suggest that in vitro 1 h drug exposure results are in good agreement with the in vivo results, while the continuous drug exposure results do not agree with the in vivo data. The most active drug in in vivo studies, deoDX, was found to be the most active drug in the in vitro 1 h drug exposure experiments as well. However, in continuous drug exposure experiments, O-DX, not deoDX, was found to be the most active drug. Activities of the other drugs tested also differed from their respective activities in in vivo studies. Although the relative effectiveness of various drugs can be compared by determining molar concentrations of the drugs producing 50% inhibition of colonies (ID50) the expression, PEI = LD10/ID50 X 1000, which takes into consideration toxicity of the drugs, is probably a better indicator of the in vitro drug activity. The results suggest that soft agar colony-formation assay (with established cell lines from the same tumor) may be used for the prediction of in vivo activity of potential antineoplastic agents against human tumor xenografts in nude mice.

摘要

一种高分化结直肠肿瘤T 219,它在无胸腺小鼠(人肿瘤裸鼠系统)中作为异种移植瘤生长,并在培养中形成集落(软琼脂集落形成试验),已被用于测试上述两种将人肿瘤细胞暴露于抗肿瘤药物方法之间的相关性。在体外研究中,使用了两种方案:1小时药物暴露和持续药物暴露。在1小时药物暴露实验中,研究了六种药物,阿霉素(DX)、4'-脱氧阿霉素(deoDX)、4'表阿霉素(epiDX)、4'-O-甲基阿霉素(O-DX)、N-三氟乙酰阿霉素-14-戊酸酯(AD-32)和5-氟尿嘧啶(FUra),而在持续药物暴露实验中,研究了上述四种药物(DX、deoDX、epiDX、O-DX)。通过计算在13 - 14天孵育期间形成的集落数量来确定肿瘤克隆形成细胞(HC219)的存活率,并获得剂量反应曲线。在体内研究中,用体外1小时药物暴露实验中使用的所有药物(DX、deoDX、epiDX、O-DX)对小鼠进行治疗。为了定量药物的化疗效果,每次测量肿瘤时计算T/C%(治疗组相对肿瘤体积占对照组的百分比)值。实验数据表明,体外1小时药物暴露结果与体内结果高度一致,而持续药物暴露结果与体内数据不一致。体内研究中最有效的药物deoDX,在体外1小时药物暴露实验中也是最有效的药物。然而,在持续药物暴露实验中,发现最有效的药物是O-DX,而不是deoDX。所测试的其他药物的活性也与其在体内研究中的各自活性不同。尽管可以通过确定产生50%集落抑制的药物的摩尔浓度(ID50)来比较各种药物的相对有效性,但考虑到药物毒性的表达式PEI = LD10/ID50×1000,可能是体外药物活性的更好指标。结果表明,软琼脂集落形成试验(使用来自同一肿瘤的已建立细胞系)可用于预测潜在抗肿瘤药物对裸鼠中人肿瘤异种移植瘤的体内活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验